Plus, news about Genentech, Mestag and BioVie:

📊 Pfizer says next-gen breast cancer drug succeeds in Phase 2: The company is developing a CDK4 inhibitor called atirmociclib as a successor to its breast cancer drug …

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844